Navigation Links
DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
Date:9/29/2009

t: 0.5em; line-height: 1.5em;">
  • Regulatory Approaches and Pathways for Global Vaccine Development: FDA, EMEA, Emerging Regions and Industry Perspectives
  • Prequalification of Global Vaccines
  • Special Presentation on Ethical Considerations in Global Vaccine Development
  • Novel Approaches to Global Vaccine Development
  • Global Vaccine Development: Path Forward and Open Dialogue
  • Speakers will include:
  • Norman Baylor, PhD, Director, Office of Vaccines Research & Review (OVRR), CBER, FDA
  • David Wood, PhD, Coordinator of the Quality, Safety & Standards Team of the Department of Immunization, Vaccines & Biologicals, WHO
  • Vincent Ahonkhai, MD: Senior Regulatory Officer, Global Health Delivery, Bill and Melinda Gates Foundation
  • Christine Grady, MSN, PhD, Head Section on Human Subjects Research, Department of Bioethics, National Institutes of Health Clinical Center
  • Jesse Goodman, MD, MPH, Acting Chief Scientist & Deputy Commissioner for Scientific & Medical Programs for FDA, will deliver the keynote address.

    "In September 2008 the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) published an important FDA Guidance Document that will expand the FDA's role in facilitating the development of new vaccines for global bacterial, viral, and parasitic diseases affecting millions of people in developing countries worldwide," explains Program Co-chair Michael Brennan, PhD, Senior Advisor for Global Affairs, Aeras Global TB Vaccine Foundation. "This symposium will explore this new guidance in depth and discuss the necessary paths to develop vaccines for global diseases."

    Click here to regis
    '/>"/>

    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved  

    Page: 1 2 3

    Related biology technology :

    1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
    2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
    3. Avicena Group to Present at Noble Financial Conference
    4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
    5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
    6. CEL-SCI to Present at the Noble Financial Conference
    7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
    8. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
    9. Strategic Diagnostics Updates Roth Conference Presentation Time
    10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
    11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
    (Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
    (Date:7/1/2015)... Mass. , July 1, 2015   ... most frequently cited advantages of Otezla are its ... safety profile, as reported by surveyed rheumatologists. Otezla ... launched for the treatment of active psoriatic arthritis ... The current standard of care includes conventional oral ...
    (Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
    (Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
    Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
    ... in reconstructive and aesthetic plastic surgeryMEDFORD, Mass., ... growth-stage medical device company developing silk-based biomaterial ... has received 510(k) clearance from the U.S. ... SeriScaffold (TM) silk-based, long term bioresorbable ...
    ... /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine ... the National Institute of Allergy and Infectious Diseases ... in Maryland, USA. The research collaboration involves formulating ... and exploring potential vaccines for HIV and malaria. ...
    ... its financial results for the year ending 31,December 2008. , , ... process for intravenous iclaprim in US, - Restructuring ... "intravenous-to-oral" Phase II trial with oral, ... - Share placing, Cash and financial investments of CHF ...
    Cached Biology Technology:Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 2Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 3Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair 4ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria 2Arpida Announces Full Year 2008 Financial Results 2Arpida Announces Full Year 2008 Financial Results 3Arpida Announces Full Year 2008 Financial Results 4Arpida Announces Full Year 2008 Financial Results 5
    (Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
    (Date:6/25/2015)... 2015 According to a ... & Area), Technology, Material (Optical Prism, Piezoelectric, Capacitive ... & Others) & Geography - Global Forecast to ... market is expected to reach $14,500.07 Million by ... Browse 76 market Tables and 109 Figures ...
    (Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
    Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
    ... privacy of patients could be hampering efforts to spot ... pollution, according to researchers in the latest edition of ... made available to research groups investigating everything from cancer ... waste sites is often restricted, altered or aggregated in ...
    ... wild-type measles virus in tissues from patients who died ... notion that the strain of virus in the measles ... November 15 issue of The Journal of Infectious Diseases, ... could prevent many more cases of the disease, known ...
    ... uneasy at the sight of amassing gulls years ago, today ... an equally uneasy eye toward migratory birds, especially in Alaska, ... last week, in Siberia. , Alaska is at the intersection ... and scientists say that could provide an unusual mixing ground ...
    Cached Biology News:Software 'agents' could help unmask reality of disease clusters 2New study shows measles immunization may prevent fatal brain infection 2On a wing and a prayer - Alaska researchers seek clues to bird flu 2On a wing and a prayer - Alaska researchers seek clues to bird flu 3
    Griess Reagent component for determination of nitrite in aqueous solutions....
    ... Removal of excess dye terminators, template DNA, ... the true sequencing products have proved critical ... product is designed to work with dye ... and DYEnamicTM ET. The unique uniformity of ...
    The Zymo-Spin PI Fast-Spin column features durable polypropylene construction and is the same column featured in the His-Spin Protein Miniprep. Capacity is 800 l....
    ... Freezing Point Osmometer for 10 L ... applications, including pediatric, neonatal, geriatric, general ... Automatic Calibration with 2 or 3 ... keypad and software for statistical analysis ...
    Biology Products: